FIELD: medicine, pharmaceutics.
SUBSTANCE: there are described steroid compounds showing higher metabolism resistance and higher water solubility, as well as methods for preparing them.
EFFECT: substances are applicable for producing pharmaceutical preparations used for treating CNS disorders associated with steroid functions or caused by steroid action, as well as according to methods for prevention, relief or treatment of said disorders.
9 cl, 19 ex, 7 tbl
| Title |
Year |
Author |
Number |
| STEROID COMPOUNDS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS WITH NERVOUS DISORDERS (VARIANTS) AND METHOD OF ANESTHESIA INDUCTION IN ANIMAL |
1995 |
- Boldzhehr Majkl B.
- Gi Kelvin U.
- Lehn Nensi K.
- Pehrdi Robert
- Takhir Khasan
- Jupehzehnaj Rehjvindra B.
|
RU2176248C2 |
| NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE |
1996 |
- Lehn Nensi K.
- Fik Dehvid B.
- Khogenkehmr Derk Dzh.
- Jupehzehnaj Rehjvindra B.
|
RU2194712C2 |
| 3α-ETHYNYL, 3β-HYDROXY, 5α-PREGNAN-20-OXIME FOR USE IN TREATING CNS DISORDERS |
2016 |
- Ragagnin Gianna
- Backstrom Torbjorn
|
RU2712786C2 |
| DERIVATIVES OF ANDROSTANE SUBSTITUTED AT 16-POSITION WITH QUATERNARY AMMONIUM GROUP, PHARMACEUTICAL COMPOSITION |
1993 |
- Zoltan Tuba
- Sil'Vester E.Vizi
- Ferents F.Foldes
- Shandor Makho
|
RU2124021C1 |
| DERIVATIVES OF 19-NORPREGNENE, PHARMACEUTICAL COMPOSITION, COMPOUNDS |
1997 |
- Alan Piasko
- Zhan Ljafaj
- Remi Delansorn
- Zhak Pari
- Zhan-Klod Paskal'
|
RU2166509C2 |
| ORGANIC COMPOUNDS |
2019 |
- Vanover, Kimberly
- Li, Peng
- Davis, Robert
- Qiao, Yupu
|
RU2809023C2 |
| STEROID COMPOUNDS, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHODS FOR REGULATION AND IMPROVING FOR REPRODUCTION, INTERMEDIATE COMPOUNDS |
2002 |
- Blume Torsten
- Ehsperling Peter
- Khegele-Khartung Krista
|
RU2289587C2 |
| METHOD OF PRODUCING 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS |
2008 |
- Khehzel'Khoff Klaus-Kristian
- Petersen Majk
|
RU2466137C2 |
| INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
1993 |
- Fernand Labri
- Iv Meran
- Shankar M.Singkh
|
RU2141967C1 |
| METHOD OF PRODUCING 3β-ACETOXY-17α-HYDROPEROXY-16α-METHYLPREGNANES FROM Δ-20-KETOSTEROIDS AND METHOD OF PRODUCING 3β-ACETOXY-17α-HYDROXY-16α-METHYLPREGNANES USING 3β-ACETOXY-17α-HYDROPEROXY-16α-METHYLPREGNANES |
2009 |
- Savinova Tat'Jana Stepanovna
- Lukashev Nikolaj Vadimovich
- Beletskaja Irina Petrovna
|
RU2418805C1 |
